A new Gallup survey found 51% of women in the United States reported negative healthcare experiences.
News|Articles|September 23, 2026
Menopause proteomic scores associated with cognitive aging, dementia risk
Author(s)Joshua Fitch, Senior Editor
Fact checked by: Benjamin P. Saylor
Menopause proteomics were consistently associated with inflammatory brain aging and Alzheimer’s dementia risk across nearly 15,000 women in a new study published in Nature Medicine.
Advertisement
Advertisement
Using blood proteomics data from multiple cohorts to identify biological changes associated with menopause, the researchers of a new study published in Nature Medicine found that “spontaneous menopause is characterized by dysregulation in inflammatory, synaptic, metabolic, and Alzheimer’s disease biologic processes, which tracked more strongly with hormones than with age.”
Related to this article
A real-world study presented at Psych Congress found that zuranolone's PPD symptom improvements were sustained through day 90.
Seventy-one percent of women miss their first perimenopausal symptom because anxiety, brain fog, and mood changes precede hot flashes—and most attribute them to stress, per the Bonafide 2026 State of Menopause Survey.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Hugh Taylor, MD, explains that imaging in endometriosis is best for ruling out other causes of pelvic pain and cannot exclude the diagnosis.
A new study links earlier menopause age to faster cognitive decline and earlier Alzheimer diagnosis.
The FDA office of Women's Health and Center for Drug Evaluation and Research and hosting a public workshop with a focus on testosterone use in menopausal women.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, weighs his own experience with pellet therapy against guideline evidence, then he and Maria Uloko, MD, close with candid advice for clinicians too afraid of hormones to start prescribing.
Advertisement
Advertisement